Daytime sleepiness in Parkinson's disease

Journal of Sleep Research

Volumn 9, Issue 1, 2000, Pages 63-69

  Rye, David B ^a   Bliwise, Donald L ^a   Dihenia, Bhupesh ^a   Gurecki, Paul ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Parkinson's disease; Pergolide; Pramipexole; Ropinirole; Sleepiness

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; LEVODOPA; PERGOLIDE; RISPERIDONE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP; SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; AROUSAL; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROOCULOGRAPHY; PHYSIOLOGY;

AGED; AROUSAL; CIRCADIAN RHYTHM; DISORDERS OF EXCESSIVE SOMNOLENCE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROOCULOGRAPHY; FEMALE; HUMANS; MALE; PARKINSON DISEASE; SLEEP, REM;

EID: 0034146539     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2869.2000.00201.x     Document Type: Article

References (38)

1. American Sleep Disorders Association Atlas Task Force. EEG arousals: scoring rules and examples. Sleep. 1992, 15: 173-184.
2. American Sleep Disorders Association Atlas Task Force. Recording and scoring leg movements. Sleep, 1993, 16: 749-759.
3. Baker, T., Guilleminault, C., Nino-Murcia, G. and Dement, W. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep, 1986, 9: 232-242.
4. Benbadis, S. R., Perry, M., Wolgamuth, B. R., Turnbull, J. and Mendelson, W. B. Mean versus median for the multiple sleep latency test. Sleep, 1995, 18: 342-345.
5. Boivin, D. B. and Montplaisir, J. The effects of 1-dopa on excessive daytime sleepiness in narcolepsy. Neurology, 1991, 41: 1267-1269.
6. Boivin, D. B., Montplaisir, J. and Poirer, G. The effects of 1-dopa on periodic leg movements and sleep organization in narcolepsy. Clin. Neuropharmacol., 1989, 12: 339-345.
7. Borbely, A. A., Akerstedt, T., Benoit, O., Holsboer, F. and Oswald, I. Hypnoties and sleep physiology: a consensus report. Eur Arch. Psychiatry Clin. Neurosci., 1991, 241: 13-21.
8. Bornstein, S. K. Respiratory monitoring during sleep: polysomnography. In: C. Guilleminault (Eds) Sleep and Waking Disorders: Indications and Techniques. Addison-Wesley, Menlo Park, CA, 1982: 183-212.
9. Carskadon, M. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep, 1986, 9: 519-524.
10. Chervin, R. D. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Sleep Res. Online, in press.
11. Daley, J., Turner, R., Bliwise, D. and Rye, D. Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep, 1999, 22 (suppl.): S218-S219.
12. Dihenia, B., Rye, D. and Bliwise, D. Daytime alertness in Parkinson's disease. Sleep Res., 1997, 26: 550.
13. Factor, S., McAlarney, T., Sanchez-Ramos, J. and Weiner, W. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord., 1990, 5: 280-285.
14. Frucht, S., Rogers, J., Greene, P., Gordon, M. and Fahn, S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology, 1999, 52: 1908-1910.
15. Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W. and Geffen, L. B. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann. Neurol., 1990, 27: 373-385.
16. Hoehn, M. M. and Yahr, M. D. Parkinsonism: onset, progression, and mortality. Neurology, 1967, 17: 427-442.
17. Hublin, C., Partinen, M., Heinonen, E. H., Puukka, P. and Salmi, T. Selegiline in the treatment of narcolepsy. Neurology, 1994, 44: 2095-2101.
18. Jellinger, K. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol., 1991, 14: 153-197.
19. Karoum, F., Chuang, L. W., Eisler, T., Calne, D. B., Liebowitz, M. R., Quitkin, F. M., Klein, D. F. and Wyatt, R. J. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Neurology, 1982, 32: 503-509.
20. Langston, J. W. and Forno, L. S. The hypothalamus in Parkinson's disease. Ann. Neurol., 1978, 3: 129-133.
21. Lees, A. J., Blackburn, N. A. and Campbell, V. L. The nighttime problems of Parkinson's Disease. Clin. Neuropharmacol., 1988, 11: 512-519.
22. Mayer, G., Ewert Meier, K. and Hephata, K. Selegiline hydrochloride treatment in narcolepsy, a double-blind, placebo-controlled study. Clin. Neuropharmacol., 1995, 18: 306-319.
23. Miller, E. and Nieburg, H. A. Amphetamines, valuable adjunct in treatment of Parkinsonism. N Y State J. Med., 1973, 73: 2657-2661.
24. Nishino, S. and Mignot, E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol., 1997, 52: 27-78.
25. Olanow, C. W., Schapira, A. H. V. and Roth, T. Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole (letter). Neurology, 2000, 54: 274-277
26. Parkes, J. D., Tarsy, D., Marsden, C. D., Bovill, K. T., Phipps, J. A., Rose, P. and Asselman, P. Amphetamines in the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 1975, 38: 232-237.
27. Rechtschaffen, A. and Kales, A., (Eds) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. US Government Printing Office, Washington, 1968.
28. Reynolds, C. F. III, Jennings, J. R., Hoch, C. C., Monk, T. H., Berman, S. R., Hall, F. T., Matizzte, J. V., Buysse, D. J. and Kupfer, D. J. Daytime sleepiness in the healthy 'old old'; a comparison with young adults. JAGS, 1991, 39: 957-962.
29. Reynolds, C. F. III, Kupfer, D. J., Taska, L. S., Hoch, C. C., Spiker, D. G., Sewitch, D. E., Zimmer, B., Marin, R. S., Nelson J. P., Martin, D. and Moryez, R. EEG sleep in elderly depressed, demented, and healthy subjects. Biol. Psychiatry, 1985, 20: 431-442.
30. Rye, D. and Bliwise, D. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: R. Watts and W. Koller (Eds) Movement Disorders: Neurologic Principles and Practice. McGraw-Hill, New York, 1997: 687-713.
31. Rye, D., Johnston, L., Watts, R. and Bliwise, D. Juvenile Parkinson's disease with REM behavior disorder, sleepiness and daytime REM-onsets. Neurology, 1999, 53: 1868-1870.
32. Sacks, O. Awakenings, E. P. Dutton, New York, 1973.
33. Schenck, C. and Mahowald, M. Motor dyscontrol in narcolepsy: rapid eye movement (REM) sleep without atonia and REM sleep behavior disorder. Ann. Neurol., 1992, 32: 3-10.
34. Scheibel, A. B. Structural and functional changes in the aging brain. In: J. E. Birren and K. W. Schaie (Eds) Handbook of the Psychology of Aging. Academic, San Diego, 1996 (fourth edition): 105-128.
35. van Hilten, J. J., Weggeman, M., van der Velde, E. A., Kerkhof, G. A., van Dijk, J. G. and Roos, R. A. C. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J. Neurol. Transm., 1993, 5: 235-244.
36. Wauquier, A., Clincke, G., van den Broek, W. and de Prins, E. Active and permissive roles of dopamine in sleep-wakefulness regulation. In: A. Wauquier, J. M. Gaillard, J. M. Monti and M. Radulovacki (Eds) Sleep: Neurotransmitters and Neuromodulators. Raven Press, New York, 1985: 107-120.
37. Williams, M. L., Irbe, D., Ansari, F. P., Rye, D. B. and Bliwise, D. L. Stage scoring reliability for nocturnal polysomnography in patients with Parkinson's Disease. Sleep, 1998, 21 (suppl.): 171.
38. Zweig, R. M., Cardillo, J. E., Cohen, M., Giere, S. and Hedreen, J. C. The locus ceruleus and dementia in Parkinson's disease. Neurology, 1993, 43: 986-991.